nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC4—Sorafenib—thyroid cancer	0.3	1	CbGbCtD
Adefovir Dipivoxil—NME1—neck—thyroid cancer	0.0226	0.102	CbGeAlD
Adefovir Dipivoxil—AK4—saliva-secreting gland—thyroid cancer	0.017	0.0763	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—head—thyroid cancer	0.0164	0.0737	CbGeAlD
Adefovir Dipivoxil—Serum creatinine increased—Vandetanib—thyroid cancer	0.0151	0.0403	CcSEcCtD
Adefovir Dipivoxil—NME1—Bosutinib—Vandetanib—thyroid cancer	0.0146	0.586	CbGdCrCtD
Adefovir Dipivoxil—AK2—thyroid gland—thyroid cancer	0.014	0.063	CbGeAlD
Adefovir Dipivoxil—AK4—trachea—thyroid cancer	0.0131	0.0589	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—thyroid cancer	0.0115	0.0516	CbGeAlD
Adefovir Dipivoxil—Hypophosphataemia—Sorafenib—thyroid cancer	0.0108	0.0288	CcSEcCtD
Adefovir Dipivoxil—NME1—thyroid gland—thyroid cancer	0.0108	0.0483	CbGeAlD
Adefovir Dipivoxil—AK4—thyroid gland—thyroid cancer	0.0104	0.0466	CbGeAlD
Adefovir Dipivoxil—NME2—thyroid gland—thyroid cancer	0.0101	0.0455	CbGeAlD
Adefovir Dipivoxil—Creatinine increased—Vandetanib—thyroid cancer	0.00979	0.026	CcSEcCtD
Adefovir Dipivoxil—NME1—head—thyroid cancer	0.00954	0.0429	CbGeAlD
Adefovir Dipivoxil—AK4—head—thyroid cancer	0.00919	0.0413	CbGeAlD
Adefovir Dipivoxil—NME2—head—thyroid cancer	0.00898	0.0404	CbGeAlD
Adefovir Dipivoxil—AK2—lymph node—thyroid cancer	0.0087	0.0391	CbGeAlD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—RET—thyroid cancer	0.00756	0.0985	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—saliva-secreting gland—thyroid cancer	0.00689	0.031	CbGeAlD
Adefovir Dipivoxil—NME1—lymph node—thyroid cancer	0.00668	0.03	CbGeAlD
Adefovir Dipivoxil—AK4—lymph node—thyroid cancer	0.00644	0.0289	CbGeAlD
Adefovir Dipivoxil—Blood creatinine increased—Vandetanib—thyroid cancer	0.00633	0.0169	CcSEcCtD
Adefovir Dipivoxil—NME2—lymph node—thyroid cancer	0.00629	0.0283	CbGeAlD
Adefovir Dipivoxil—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00596	0.0159	CcSEcCtD
Adefovir Dipivoxil—ABCC5—thyroid gland—thyroid cancer	0.00588	0.0265	CbGeAlD
Adefovir Dipivoxil—Pancreatitis—Vandetanib—thyroid cancer	0.00573	0.0152	CcSEcCtD
Adefovir Dipivoxil—NME1—Afatinib—Vandetanib—thyroid cancer	0.00552	0.221	CbGdCrCtD
Adefovir Dipivoxil—Weight decreased—Vandetanib—thyroid cancer	0.00529	0.0141	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00522	0.0139	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Vandetanib—thyroid cancer	0.00512	0.0136	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Sorafenib—thyroid cancer	0.00508	0.0135	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Vandetanib—thyroid cancer	0.00497	0.0132	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00493	0.0131	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Vandetanib—thyroid cancer	0.00489	0.013	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—TSHR—thyroid cancer	0.00483	0.0629	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Gefitinib—Vandetanib—thyroid cancer	0.00483	0.193	CbGdCrCtD
Adefovir Dipivoxil—Kidney function abnormal—Epirubicin—thyroid cancer	0.00481	0.0128	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Vandetanib—thyroid cancer	0.00462	0.0123	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Vandetanib—thyroid cancer	0.00459	0.0122	CcSEcCtD
Adefovir Dipivoxil—Kidney function abnormal—Doxorubicin—thyroid cancer	0.00445	0.0118	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—thyroid gland—thyroid cancer	0.0042	0.0189	CbGeAlD
Adefovir Dipivoxil—ABCC4—thyroid gland—thyroid cancer	0.00408	0.0183	CbGeAlD
Adefovir Dipivoxil—Malnutrition—Vandetanib—thyroid cancer	0.00407	0.0108	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00402	0.0107	CcSEcCtD
Adefovir Dipivoxil—Hypophosphataemia—Epirubicin—thyroid cancer	0.004	0.0106	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Sorafenib—thyroid cancer	0.00387	0.0103	CcSEcCtD
Adefovir Dipivoxil—Serum creatinine increased—Epirubicin—thyroid cancer	0.00378	0.01	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—head—thyroid cancer	0.00373	0.0168	CbGeAlD
Adefovir Dipivoxil—Hypophosphataemia—Doxorubicin—thyroid cancer	0.0037	0.00984	CcSEcCtD
Adefovir Dipivoxil—ABCC5—lymph node—thyroid cancer	0.00365	0.0164	CbGeAlD
Adefovir Dipivoxil—ABCC4—head—thyroid cancer	0.00362	0.0163	CbGeAlD
Adefovir Dipivoxil—SLC22A8—head—thyroid cancer	0.00359	0.0161	CbGeAlD
Adefovir Dipivoxil—Weight decreased—Sorafenib—thyroid cancer	0.00357	0.00949	CcSEcCtD
Adefovir Dipivoxil—Cough—Vandetanib—thyroid cancer	0.00355	0.00945	CcSEcCtD
Adefovir Dipivoxil—Serum creatinine increased—Doxorubicin—thyroid cancer	0.00349	0.00929	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Vandetanib—thyroid cancer	0.00347	0.00922	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Sorafenib—thyroid cancer	0.00346	0.00919	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00344	0.00916	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Sorafenib—thyroid cancer	0.00343	0.00911	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00332	0.00884	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Vandetanib—thyroid cancer	0.00326	0.00867	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Vandetanib—thyroid cancer	0.00325	0.00866	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Vandetanib—thyroid cancer	0.00323	0.00859	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Sorafenib—thyroid cancer	0.00312	0.00829	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Sorafenib—thyroid cancer	0.0031	0.00825	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Sorafenib—thyroid cancer	0.00309	0.00823	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00303	0.00805	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Vandetanib—thyroid cancer	0.00293	0.00778	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Vandetanib—thyroid cancer	0.00289	0.00769	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00287	0.00763	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Epirubicin—thyroid cancer	0.00287	0.00763	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Sorafenib—thyroid cancer	0.00275	0.00731	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00272	0.00723	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Defective B3GAT3 causes JDSSDHD—CHST14—thyroid cancer	0.00268	0.0349	CbGpPWpGaD
Adefovir Dipivoxil—Glycosuria—Doxorubicin—thyroid cancer	0.00265	0.00706	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Vandetanib—thyroid cancer	0.00263	0.00699	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Vandetanib—thyroid cancer	0.00263	0.00699	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—lymph node—thyroid cancer	0.00261	0.0117	CbGeAlD
Adefovir Dipivoxil—Anaemia—Sorafenib—thyroid cancer	0.00254	0.00675	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Epirubicin—thyroid cancer	0.00254	0.00675	CcSEcCtD
Adefovir Dipivoxil—ABCC4—lymph node—thyroid cancer	0.00253	0.0114	CbGeAlD
Adefovir Dipivoxil—Creatinine increased—Epirubicin—thyroid cancer	0.00244	0.00649	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Epirubicin—thyroid cancer	0.00242	0.00645	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00242	0.0316	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Sorafenib—thyroid cancer	0.0024	0.00638	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Vandetanib—thyroid cancer	0.00238	0.00634	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Vandetanib—thyroid cancer	0.00235	0.00625	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Doxorubicin—thyroid cancer	0.00235	0.00624	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Sorafenib—thyroid cancer	0.00234	0.00622	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00232	0.00618	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Epirubicin—thyroid cancer	0.00232	0.00618	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Epirubicin—thyroid cancer	0.00228	0.00607	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Vandetanib—thyroid cancer	0.00227	0.00605	CcSEcCtD
Adefovir Dipivoxil—Creatinine increased—Doxorubicin—thyroid cancer	0.00226	0.006	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Doxorubicin—thyroid cancer	0.00224	0.00597	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Sorafenib—thyroid cancer	0.0022	0.00585	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Sorafenib—thyroid cancer	0.0022	0.00584	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Sorafenib—thyroid cancer	0.00218	0.00579	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00215	0.00572	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Sorafenib—thyroid cancer	0.00214	0.00568	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Vandetanib—thyroid cancer	0.00211	0.00562	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00211	0.00562	CcSEcCtD
Adefovir Dipivoxil—Rash—Vandetanib—thyroid cancer	0.0021	0.00557	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Vandetanib—thyroid cancer	0.00209	0.00557	CcSEcCtD
Adefovir Dipivoxil—Headache—Vandetanib—thyroid cancer	0.00208	0.00554	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TERT—thyroid cancer	0.00205	0.0268	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00204	0.00543	CcSEcCtD
Adefovir Dipivoxil—Nausea—Vandetanib—thyroid cancer	0.00197	0.00525	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Sorafenib—thyroid cancer	0.00197	0.00525	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Sorafenib—thyroid cancer	0.00195	0.00518	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00194	0.00515	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00193	0.00513	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Epirubicin—thyroid cancer	0.00188	0.00499	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00183	0.00488	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00178	0.00475	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Sorafenib—thyroid cancer	0.00177	0.00471	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Sorafenib—thyroid cancer	0.00177	0.00471	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Epirubicin—thyroid cancer	0.00177	0.00471	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Doxorubicin—thyroid cancer	0.00174	0.00462	CcSEcCtD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—CCND1—thyroid cancer	0.00169	0.022	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00168	0.0219	CbGpPWpGaD
Adefovir Dipivoxil—Renal impairment—Doxorubicin—thyroid cancer	0.00164	0.00436	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Sorafenib—thyroid cancer	0.00161	0.00428	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Sorafenib—thyroid cancer	0.00159	0.00422	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Epirubicin—thyroid cancer	0.00158	0.0042	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—TRIM33—thyroid cancer	0.00156	0.0204	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TERT—thyroid cancer	0.00156	0.0203	CbGpPWpGaD
Adefovir Dipivoxil—Liver function test abnormal—Epirubicin—thyroid cancer	0.00156	0.00414	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Sorafenib—thyroid cancer	0.00153	0.00408	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—MINPP1—thyroid cancer	0.0015	0.0196	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00149	0.00396	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00146	0.00389	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00144	0.00383	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—CHST14—thyroid cancer	0.00144	0.0187	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Epirubicin—thyroid cancer	0.00143	0.0038	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Sorafenib—thyroid cancer	0.00143	0.00379	CcSEcCtD
Adefovir Dipivoxil—Rash—Sorafenib—thyroid cancer	0.00141	0.00376	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Sorafenib—thyroid cancer	0.00141	0.00376	CcSEcCtD
Adefovir Dipivoxil—Headache—Sorafenib—thyroid cancer	0.0014	0.00374	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00138	0.00366	CcSEcCtD
Adefovir Dipivoxil—Nausea—Sorafenib—thyroid cancer	0.00133	0.00354	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Doxorubicin—thyroid cancer	0.00132	0.00352	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Epirubicin—thyroid cancer	0.00132	0.00351	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—NDUFA13—thyroid cancer	0.00128	0.0167	CbGpPWpGaD
Adefovir Dipivoxil—Renal failure—Epirubicin—thyroid cancer	0.00128	0.0034	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Epirubicin—thyroid cancer	0.00127	0.00337	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Epirubicin—thyroid cancer	0.00124	0.00329	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00123	0.00327	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—thyroid cancer	0.00122	0.00324	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—thyroid cancer	0.00122	0.00324	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—CHST14—thyroid cancer	0.0012	0.0157	CbGpPWpGaD
Adefovir Dipivoxil—Renal failure—Doxorubicin—thyroid cancer	0.00118	0.00314	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Doxorubicin—thyroid cancer	0.00117	0.00312	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00117	0.0153	CbGpPWpGaD
Adefovir Dipivoxil—Hepatitis—Epirubicin—thyroid cancer	0.00117	0.0031	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—thyroid cancer	0.00116	0.00308	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—thyroid cancer	0.00115	0.00306	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Doxorubicin—thyroid cancer	0.00115	0.00305	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—thyroid cancer	0.00115	0.00305	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—thyroid cancer	0.00114	0.00304	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00114	0.00302	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—thyroid cancer	0.00113	0.003	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—thyroid cancer	0.00108	0.00287	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—thyroid cancer	0.00107	0.00285	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00107	0.00283	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00106	0.00282	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—thyroid cancer	0.00106	0.00281	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00106	0.0138	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—TCF7L1—thyroid cancer	0.00104	0.0136	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—MINPP1—thyroid cancer	0.00104	0.0136	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Epirubicin—thyroid cancer	0.00102	0.0027	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Epirubicin—thyroid cancer	0.001	0.00266	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000989	0.0129	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Epirubicin—thyroid cancer	0.000982	0.00261	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—HPGD—thyroid cancer	0.000969	0.0126	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—thyroid cancer	0.000939	0.0025	CcSEcCtD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—thyroid cancer	0.000938	0.0122	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Epirubicin—thyroid cancer	0.000938	0.0025	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Doxorubicin—thyroid cancer	0.000926	0.00246	CcSEcCtD
Adefovir Dipivoxil—Back pain—Doxorubicin—thyroid cancer	0.000909	0.00242	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—NDUFA13—thyroid cancer	0.000887	0.0116	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Epirubicin—thyroid cancer	0.000886	0.00236	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000881	0.0115	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Doxorubicin—thyroid cancer	0.000868	0.00231	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—thyroid cancer	0.000864	0.0023	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Epirubicin—thyroid cancer	0.000864	0.0023	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000858	0.00228	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—thyroid cancer	0.000844	0.011	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CHST14—thyroid cancer	0.000834	0.0109	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Doxorubicin—thyroid cancer	0.00082	0.00218	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—thyroid cancer	0.000813	0.00216	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—thyroid cancer	0.000811	0.00216	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Epirubicin—thyroid cancer	0.000805	0.00214	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—thyroid cancer	0.0008	0.00213	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Doxorubicin—thyroid cancer	0.0008	0.00213	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000794	0.00211	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—MINPP1—thyroid cancer	0.00079	0.0103	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Epirubicin—thyroid cancer	0.00079	0.0021	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SLC5A5—thyroid cancer	0.000788	0.0103	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.000782	0.0102	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000755	0.00201	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—thyroid cancer	0.000752	0.002	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000751	0.002	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—thyroid cancer	0.000745	0.00198	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Doxorubicin—thyroid cancer	0.000731	0.00194	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—thyroid cancer	0.000729	0.00194	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—thyroid cancer	0.00072	0.00192	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000715	0.0019	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000698	0.00186	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000678	0.0018	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—thyroid cancer	0.000675	0.0018	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—HPGD—thyroid cancer	0.000672	0.00876	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NDUFA13—thyroid cancer	0.000672	0.00876	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—thyroid cancer	0.000666	0.00177	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—TPR—thyroid cancer	0.000666	0.00867	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—RXRA—thyroid cancer	0.000662	0.00863	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000662	0.00176	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—thyroid cancer	0.000655	0.00174	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—thyroid cancer	0.000655	0.00174	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000643	0.00838	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CHST14—thyroid cancer	0.000632	0.00823	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000627	0.00167	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—thyroid cancer	0.000606	0.00161	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—thyroid cancer	0.000606	0.00161	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Epirubicin—thyroid cancer	0.000594	0.00158	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.000593	0.00772	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Epirubicin—thyroid cancer	0.000586	0.00156	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—NRG1—thyroid cancer	0.000573	0.00746	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—thyroid cancer	0.000567	0.00151	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—TPR—thyroid cancer	0.000557	0.00725	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Doxorubicin—thyroid cancer	0.00055	0.00146	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PRKAR1A—thyroid cancer	0.000548	0.00714	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SLC5A5—thyroid cancer	0.000546	0.00712	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Doxorubicin—thyroid cancer	0.000542	0.00144	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000532	0.00694	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000532	0.00694	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Epirubicin—thyroid cancer	0.000527	0.0014	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—thyroid cancer	0.000525	0.0014	CcSEcCtD
Adefovir Dipivoxil—Rash—Epirubicin—thyroid cancer	0.000522	0.00139	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—thyroid cancer	0.000522	0.00139	CcSEcCtD
Adefovir Dipivoxil—Headache—Epirubicin—thyroid cancer	0.000519	0.00138	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—HPGD—thyroid cancer	0.000509	0.00664	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Epirubicin—thyroid cancer	0.000492	0.00131	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000491	0.0064	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Doxorubicin—thyroid cancer	0.000487	0.0013	CcSEcCtD
Adefovir Dipivoxil—Rash—Doxorubicin—thyroid cancer	0.000483	0.00129	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—thyroid cancer	0.000483	0.00128	CcSEcCtD
Adefovir Dipivoxil—Headache—Doxorubicin—thyroid cancer	0.00048	0.00128	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00048	0.00625	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00048	0.00625	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—RXRA—thyroid cancer	0.000459	0.00598	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Doxorubicin—thyroid cancer	0.000455	0.00121	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000446	0.00581	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000444	0.00578	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TRIM24—thyroid cancer	0.000433	0.00565	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000428	0.00558	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MINPP1—thyroid cancer	0.000427	0.00556	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—SLC5A5—thyroid cancer	0.000417	0.00543	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CHST14—thyroid cancer	0.000407	0.00531	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.0004	0.00522	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	0.0004	0.00522	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000398	0.00519	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—NRG1—thyroid cancer	0.000397	0.00517	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TRIM33—thyroid cancer	0.000386	0.00503	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—TPR—thyroid cancer	0.000386	0.00503	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PRKAR1A—thyroid cancer	0.00038	0.00495	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NDUFA13—thyroid cancer	0.000363	0.00473	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000359	0.00468	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—RXRA—thyroid cancer	0.00035	0.00456	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MINPP1—thyroid cancer	0.000342	0.00446	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CHST14—thyroid cancer	0.000341	0.00445	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—CP—thyroid cancer	0.000337	0.00439	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000337	0.00439	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000332	0.00432	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000329	0.00429	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.0003	0.00391	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TPR—thyroid cancer	0.000292	0.00381	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000292	0.00381	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NDUFA13—thyroid cancer	0.000291	0.00379	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—SLC5A5—thyroid cancer	0.000289	0.00376	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PRKAR1A—thyroid cancer	0.000288	0.00375	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HPGD—thyroid cancer	0.000275	0.00358	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CHST14—thyroid cancer	0.000274	0.00357	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.00027	0.00352	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00027	0.00352	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000266	0.00347	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PRKAR1A—thyroid cancer	0.000266	0.00346	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TCF7L1—thyroid cancer	0.000258	0.00336	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000252	0.00329	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000247	0.00322	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000244	0.00318	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—CP—thyroid cancer	0.000244	0.00318	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—RXRA—thyroid cancer	0.000243	0.00316	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00024	0.00313	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—CP—thyroid cancer	0.000234	0.00305	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000234	0.00305	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00023	0.003	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PPARG—thyroid cancer	0.000221	0.00288	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HPGD—thyroid cancer	0.000221	0.00287	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—SLC5A5—thyroid cancer	0.000219	0.00285	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000212	0.00276	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000203	0.00265	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000203	0.00265	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000202	0.00264	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.0002	0.00261	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TPR—thyroid cancer	0.000189	0.00246	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PRKAR1A—thyroid cancer	0.000186	0.00242	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—RXRA—thyroid cancer	0.000184	0.0024	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000183	0.00238	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MEN1—thyroid cancer	0.000177	0.00231	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IFNA2—thyroid cancer	0.000176	0.00229	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000175	0.00228	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTGS2—thyroid cancer	0.000174	0.00227	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00017	0.00222	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TPR—thyroid cancer	0.000158	0.00206	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PRKAR1A—thyroid cancer	0.000155	0.00202	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000153	0.002	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PPARG—thyroid cancer	0.000153	0.002	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000152	0.00198	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTEN—thyroid cancer	0.000152	0.00198	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000147	0.00192	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CALCA—thyroid cancer	0.000141	0.00184	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000128	0.00167	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDK1—thyroid cancer	0.000128	0.00167	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TPR—thyroid cancer	0.000127	0.00165	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PRKAR1A—thyroid cancer	0.000125	0.00162	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—thyroid cancer	0.000121	0.00157	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC5A5—thyroid cancer	0.000118	0.00154	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPARG—thyroid cancer	0.000116	0.00151	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTEN—thyroid cancer	0.000105	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NRG1—thyroid cancer	0.000103	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—RXRA—thyroid cancer	9.93e-05	0.00129	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC5A5—thyroid cancer	9.48e-05	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TERT—thyroid cancer	9.21e-05	0.0012	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—thyroid cancer	9.14e-05	0.00119	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HIF1A—thyroid cancer	8.81e-05	0.00115	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—thyroid cancer	8.74e-05	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	8.22e-05	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTEN—thyroid cancer	7.97e-05	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—RXRA—thyroid cancer	7.97e-05	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—BRAF—thyroid cancer	7.29e-05	0.00095	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NRAS—thyroid cancer	6.56e-05	0.000855	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPARG—thyroid cancer	6.27e-05	0.000817	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—thyroid cancer	6.06e-05	0.00079	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—thyroid cancer	5.89e-05	0.000768	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KRAS—thyroid cancer	5.65e-05	0.000736	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTEN—thyroid cancer	5.14e-05	0.000669	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPARG—thyroid cancer	5.03e-05	0.000655	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—thyroid cancer	5.02e-05	0.000654	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—thyroid cancer	4.93e-05	0.000643	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—thyroid cancer	4.8e-05	0.000626	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—thyroid cancer	4.59e-05	0.000598	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NRAS—thyroid cancer	4.58e-05	0.000597	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTEN—thyroid cancer	4.3e-05	0.000561	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—thyroid cancer	4.24e-05	0.000552	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—thyroid cancer	3.96e-05	0.000516	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KRAS—thyroid cancer	3.95e-05	0.000514	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTEN—thyroid cancer	3.45e-05	0.00045	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—thyroid cancer	3.35e-05	0.000437	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—thyroid cancer	2.96e-05	0.000386	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—thyroid cancer	2.48e-05	0.000323	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—thyroid cancer	1.99e-05	0.000259	CbGpPWpGaD
